CoChat

Metal-catalyzed oxidation of Aβ and the resulting reorganization of Cu binding sites promote ROS production

Open access

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

Aβ oxidation due to HO˙ production by Cu–Aβ/ascorbate changes copper coordination and leads to the self-enhancement of HO˙ production and release.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1039/c6mt00150e

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 (a) Cu(ii) coordination and (b) Cu(i) coordination to the Aβ peptide.16, 20
Fig. 1 (a) Cu(ii) coordination and (b) Cu(i) coordination to the Aβ peptide.16, 20CC BY-NC · PubMed Central
Fig. 2 Amino acid sequence of the Aβ28 peptide (top) along with the main targeted amino acid residues (in color) and the chemical structure of the oxidation products (bottom). Asp1 oxidation leads to the formation of either an isocyanate or a pyruvate function21,25 (green) and His13 and His14 oxidation reactions lead to the formation of 2-oxohistidines21,23,24 (blue).
Fig. 2 Amino acid sequence of the Aβ28 peptide (top) along with the main targeted amino acid residues (in color) and the chemical structure of the oxidation products (bottom). Asp1 oxidation leads to the formation of either an isocyanate or a pyruvate function21,25 (green) and His13 and His14 oxidation reactions lead to the formation of 2-oxohistidines21,23,24 (blue).CC BY-NC · PubMed Central
Fig. 3 Cu XANES K-edge X-ray absorption spectra of Aβ28–Cu(i) (black curve), Aβox–Cu(i) (blue curve) and Aβ7–Cu(i) (grey curve). The conditions were as follows: 0.9 mM Cu(ii), 1 mM peptide, and 10 mM dithionite in a HEPES buffer (0.1 M, pH 7.1) solution. Arrows indicate the evolution of the Aβox–Cu(i) signature compared with the Aβ28–Cu(i) signature. Inset: zoom of the 8970–9090 eV range.
Fig. 3 Cu XANES K-edge X-ray absorption spectra of Aβ28–Cu(i) (black curve), Aβox–Cu(i) (blue curve) and Aβ7–Cu(i) (grey curve). The conditions were as follows: 0.9 mM Cu(ii), 1 mM peptide, and 10 mM dithionite in a HEPES buffer (0.1 M, pH 7.1) solution. Arrows indicate the evolution of the Aβox–Cu(i) signature compared with the Aβ28–Cu(i) signature. Inset: zoom of the 8970–9090 eV range.CC BY-NC · PubMed Central
Fig. 4 EPR spectra of Cu(ii)–Aβox (blue curve), Cu(ii)–Aβ28 (black curve) and Cu(ii)–AcAβ28 (grey curve) at pH 12.5. Aqueous solution with 10% of glycerol containing 65Cu (450 μM) and peptide (500 μM). T = 120 K, ν = 9.5 GHz, microwave power = 20.5 mW, amplitude modulation = 10.0 G, and modulation frequency = 100 kHz.
Fig. 4 EPR spectra of Cu(ii)–Aβox (blue curve), Cu(ii)–Aβ28 (black curve) and Cu(ii)–AcAβ28 (grey curve) at pH 12.5. Aqueous solution with 10% of glycerol containing 65Cu (450 μM) and peptide (500 μM). T = 120 K, ν = 9.5 GHz, microwave power = 20.5 mW, amplitude modulation = 10.0 G, and modulation frequency = 100 kHz.CC BY-NC · PubMed Central
Fig. 5 (a) Ascorbate consumption by Cu–Aβ28 (black curve), Cu–Aβox (blue curve), Cu–Aβ7 (grey curve) and free Cu (dashed curve) measured using UV spectrophotometry (λ = 265 nm) as a function of the reaction time; phosphate buffered solution (50 mM, pH 7.4), Cu(ii) 10 μM, peptide 12 μM and ascorbate 100 μM. (b) Fluorescence as a function of the time of 7-OH-CCA resulting from the oxidation of CCA obtained for Cu–Aβ28 (black curve), Cu–Aβox (blue curve), Cu–Aβ7 (grey curve) and free Cu (dashed curve); phosphate buffered solution (50 mM, pH 7.4), Cu(ii) 50 μM, peptide 60 μM (oxidized or non-oxidized), ascorbate 500 μM and CCA 500 μM.
Fig. 5 (a) Ascorbate consumption by Cu–Aβ28 (black curve), Cu–Aβox (blue curve), Cu–Aβ7 (grey curve) and free Cu (dashed curve) measured using UV spectrophotometry (λ = 265 nm) as a function of the reaction time; phosphate buffered solution (50 mM, pH 7.4), Cu(ii) 10 μM, peptide 12 μM and ascorbate 100 μM. (b) Fluorescence as a function of the time of 7-OH-CCA resulting from the oxidation of CCA obtained for Cu–Aβ28 (black curve), Cu–Aβox (blue curve), Cu–Aβ7 (grey curve) and free Cu (dashed curve); phosphate buffered solution (50 mM, pH 7.4), Cu(ii) 50 μM, peptide 60 μM (oxidized or non-oxidized), ascorbate 500 μM and CCA 500 μM.CC BY-NC · PubMed Central
Fig. 6 (a) Remaining non-oxidized Aβ28 after successive additions of ascorbate (4 nmol, final conc. 20 μM) or ascorbate/H2O2 (4/10 nmol, final conc. 20/50 μM). Aβ28 25 μM and Cu2+ 20 μM, phosphate buffered pH 7.4 (50 mM). Ordinate: ratio between the peak area of non-oxidized Aβ28 and the reference peak area of non-ox Aβ28 (no addition of ascorbate nor H2O2). HPLC/HRMS, m/z 1087.8503, 816.1397, 653.1133 ([M + nH]n+, n = 3, 4, 5), 5 ppm accuracy. (b) Ascorbate consumption measured at 265 nm as a function of the reaction time; Aβ28 25 μM, Cu2+ 20 μM, phosphate buffered pH 7.4 (50 mM), ascorbate 20 μM, with or without H2O2 50 μM.
Fig. 6 (a) Remaining non-oxidized Aβ28 after successive additions of ascorbate (4 nmol, final conc. 20 μM) or ascorbate/H2O2 (4/10 nmol, final conc. 20/50 μM). Aβ28 25 μM and Cu2+ 20 μM, phosphate buffered pH 7.4 (50 mM). Ordinate: ratio between the peak area of non-oxidized Aβ28 and the reference peak area of non-ox Aβ28 (no addition of ascorbate nor H2O2). HPLC/HRMS, m/z 1087.8503, 816.1397, 653.1133 ([M + nH]n+, n = 3, 4, 5), 5 ppm accuracy. (b) Ascorbate consumption measured at 265 nm as a function of the reaction time; Aβ28 25 μM, Cu2+ 20 μM, phosphate buffered pH 7.4 (50 mM), ascorbate 20 μM, with or without H2O2 50 μM.CC BY-NC · PubMed Central
Fig. 7 Oxidation of Aβ in the absence or presence of H2O2. Trace chromatograms obtained by HPLC/HRMS of the Aβ oxidized tryptic peptides DAEFRdd (decarboxylation and deamination of Asp1), DAEFRox (oxidative fragmentation of Asp1), and HDSGYEVHHQK + 16 after 1 (black curve), 2 (dark grey curve) or 3 (light grey curve) additions of ascorbate (4 nmol, final conc. 20 μM; left panel) or ascorbate/H2O2 (4/10 nmol, final conc. 20/50 μM; right panel). Aβ28 25 μM and Cu(ii) 20 μM, phosphate buffered pH 7.4 (50 mM). Mass tolerance set at 5 ppm; m/z ratios used for the detection are specified in Table S1 (ESI†). The corresponding raw chromatograms are given in Fig. S7–S9 (ESI†). The oxidized residues were identified by HR-MS (Asp1 oxidation, see Table S2, ESI†) and by MS/MS (His13 and His14 oxidation reactions, see Fig. S10 and S11, ESI†).
Fig. 7 Oxidation of Aβ in the absence or presence of H2O2. Trace chromatograms obtained by HPLC/HRMS of the Aβ oxidized tryptic peptides DAEFRdd (decarboxylation and deamination of Asp1), DAEFRox (oxidative fragmentation of Asp1), and HDSGYEVHHQK + 16 after 1 (black curve), 2 (dark grey curve) or 3 (light grey curve) additions of ascorbate (4 nmol, final conc. 20 μM; left panel) or ascorbate/H2O2 (4/10 nmol, final conc. 20/50 μM; right panel). Aβ28 25 μM and Cu(ii) 20 μM, phosphate buffered pH 7.4 (50 mM). Mass tolerance set at 5 ppm; m/z ratios used for the detection are specified in Table S1 (ESI†). The corresponding raw chromatograms are given in Fig. S7–S9 (ESI†). The oxidized residues were identified by HR-MS (Asp1 oxidation, see Table S2, ESI†) and by MS/MS (His13 and His14 oxidation reactions, see Fig. S10 and S11, ESI†).CC BY-NC · PubMed Central
Fig. 8 Cu–Aβ induced HO• trapped by CCA. Fluorescence intensity at the plateau of phosphate buffered solution (50 mM) containing Cu (20 μM), peptide (25 μM), and CCA (0.5 mM) as a function of the number of ascorbate and H2O2 additions. A total of 8 additions of 2 μL ascorbate (2 mM) and 2 μL hydrogen peroxide (5 mM) are realized, i.e. 4 and 10 nmol for each addition respectively (initial concentrations reaching 20 and 50 μM for the first addition, respectively). Gradients of the linear parts of the curves are indicated in black. The gradient and determination coefficients of fits for each curve are given in the ESI,† Table S3.
Fig. 8 Cu–Aβ induced HO• trapped by CCA. Fluorescence intensity at the plateau of phosphate buffered solution (50 mM) containing Cu (20 μM), peptide (25 μM), and CCA (0.5 mM) as a function of the number of ascorbate and H2O2 additions. A total of 8 additions of 2 μL ascorbate (2 mM) and 2 μL hydrogen peroxide (5 mM) are realized, i.e. 4 and 10 nmol for each addition respectively (initial concentrations reaching 20 and 50 μM for the first addition, respectively). Gradients of the linear parts of the curves are indicated in black. The gradient and determination coefficients of fits for each curve are given in the ESI,† Table S3.CC BY-NC · PubMed Central
Fig. 9 Fluorescence intensity at the plateau of phosphate buffered solution (50 mM) containing 20 μM of Cu, 25 μM (blue curve) or 50 μM (grey curve) of the Aβ16 peptide, and CCA (0.5 mM) as a function of the number of ascorbate and H2O2 additions. A total of 8 additions of 2 μL ascorbate (2 mM) and 2 μL hydrogen peroxide (5 mM) are realized, i.e. 4 and 10 nmol for each addition respectively (initial concentrations reaching 20 and 50 μM for the first addition, respectively). Gradients of the linear parts of the curves are indicated in black. The gradient and determination coefficients of fits for each curve are given in the ESI,† Table S3
Fig. 9 Fluorescence intensity at the plateau of phosphate buffered solution (50 mM) containing 20 μM of Cu, 25 μM (blue curve) or 50 μM (grey curve) of the Aβ16 peptide, and CCA (0.5 mM) as a function of the number of ascorbate and H2O2 additions. A total of 8 additions of 2 μL ascorbate (2 mM) and 2 μL hydrogen peroxide (5 mM) are realized, i.e. 4 and 10 nmol for each addition respectively (initial concentrations reaching 20 and 50 μM for the first addition, respectively). Gradients of the linear parts of the curves are indicated in black. The gradient and determination coefficients of fits for each curve are given in the ESI,† Table S3CC BY-NC · PubMed Central
Scheme 1 Metal-catalyzed Reactive Oxygen Species (ROS) production in the presence of the amyloid-β peptide (Aβ); Asc = ascorbate, DHA = dehydroascorbate.
Scheme 1 Metal-catalyzed Reactive Oxygen Species (ROS) production in the presence of the amyloid-β peptide (Aβ); Asc = ascorbate, DHA = dehydroascorbate.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 47 references

Research works printed but not linked: 2

  1. R. A. Farhataziz and A.Ross , Hydroxyl radical and perhydroxyl radical and their radical ions , NSRDS-NBS, 1977 , vol. 59
  2. Hureau, 2012, Coord. Chem. Rev., 256, 2164, 10.1016/j.ccr.2012.03.037 · DOI · Paper page

Cited by

See all 81

Metadata

Authors
Cheignon, C., Faller, P., Testemale, D., Hureau, C., & Collin, F.
Affiliations
Centre National de la Recherche Scientifique (FR)
Corresponding author
  • Faller, Peter
  • Collin, Fabrice
Venue
Metallomics
Published
2016
Volume
8
Issue
10
Pages
1081-1089
ISSN
  • 1756-5901 (ISSN-L)
  • 1756-591X
OpenAlex
W2510892825
Cited by
81
References
47
Citations by year
2026: 8 · 2025: 9 · 2024: 5 · 2023: 11 · 2022: 6 · 2021: 8 · 2020: 7 · 2019: 5 · 2018: 8 · 2017: 12 · 2016: 2
FWCI
7.24
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Metallomics (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion, cc-by-nc)
  • HAL (submittedVersion, other-oa)
Funders
  • Agence Nationale de la Recherche (ANR-13-BSV5-0016)
  • European Research Council (aLzINK - contract n? 638712)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Physical Sciences › Chemistry › Inorganic Chemistry › Metal-Catalyzed Oxygenation Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
Keywords
metal-catalyzed oxidation, amyloid-beta, copper coordination, copper binding site, hydroxyl radical generation, vitamin C, oxidative stress, Alzheimer's disease, peptide oxidation
MeSH terms
Alzheimer Disease, Amino Acid Sequence, Ascorbic Acid, Binding Sites, Copper, Humans, Oxidation-Reduction, Amyloid beta-Peptides, Reactive Oxygen Species, Oxidative Stress

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.